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Members of the NF-KB transcription factor family serve 
as a prototypical model of inducible transcription factors. 
As discussed below, NF-KB activity is primarily regulated 
by a group of structurally related proteins collectively re- 
ferred to as IKB (for recent reviews on NF-KB and IKB, 
see Beg and Baldwin, 1993; Gilmore and Morin, 1993; 
Siebenlist et al., 1994; Baeuerle and Henkel, 1994; 
Thanos and Maniatis, 1995). The NF-KB transcription fac- 
tor family is an important component in a variety of biologi- 
cal processes, most notably inflammation and immune 
responses. The requirement for NF-KB in these processes 
is indicated by its ability to regulate genes whose products 
are critical for these cellular events. These products in- 
clude cytokines, immunoreceptors, cell adhesion mole- 
cules, and acute phase proteins (Siebenlist et al., 1994; 
Baeuerle and Henkel, 1994). In addition, recent research 
has shown dramatically that mice containing targeted dis- 
ruptions of NF-KB subunits are compromised in various 
aspects of immune function and inflammatory responses 
(Weih et al., 1995; Sha et al., 1995; Burkly et al., 1995; 
Kontgen et al., 1995; also see Thanos and Maniatis, 1995). 
A number of pathogenic viruses, including the human im- 
munodeficiency virus, also subvert NF-KB activity for the 
expression of essential viral genes (Nabel and Baltimore, 
1987; Siebenlist et al., 1994; Baeuerle and Henkel, 1994). 
Finally, genetic alterations in the structure or expression 
of genes encoding NF-KB and IKB family members can 
render these proteins oncogenic, demonstrating an inti- 
mate relationship between NF-~Bfunction and normal cel- 
lular proliferation (Siebenlist et al., 1994; Baeuerle and 
Henkel, 1994). In this review, we discuss the mechanisms 
regulating NF-KB activity. A particular emphasis has been 
placed on recent studies, which more clearly define how 
various modifications to IKB, specifically inducible phos- 
phorylation, ubiquitination, and proteasome-driven degra- 
dation, contribute to NF-KB activation. 
NF-KB Is an Inducible Transcription Factor 
Research performed in the late 1980s elegantly demon- 
strated the inducible nature of NF-KB. These studies re- 
vealed that NF-KB is primarily regulated by its localization 
within the cell (Baeuerle and Baltimore, 1988a). In most 
circumstances, NF-KB is sequestered in the cytoplasm 
through its interaction with a group of inhibitory molecules 
termed IKB (Baeuerle and Baltimore, 1988b). Treatment 
of cells with various inducers, including tumor necrosis 
factor(TNF), interleukin-1 (IL-l), lipopolysaccharide(LPS), 
phorbol esters, and serum growth factors results in the 
dissociation of IKB from NF-KB (Siebenlist et al., 1994; 
Baeuerle and Henkel, 1994). IKB displacement exposes 
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the nuclear localization signal of NF-KB, thereby allowing 
translocation of the transcription factor into the nucleus, 
where it modulates gene expression (Beg et al., 1992; 
Ganchi et al., 1992; Zabel et al., 1993). Thus, the dissocia- 
tion of IKB from NF-KB is the critical limiting step in the 
activation process. The translocation of NF-KB into the 
nucleus is remarkably rapid, usually occurring within mi- 
nutes of cellular stimulation. This rapidity, and the obser- 
vation that activation does not require protein synthesis 
(Sen and Baltimore, 1986), strongly implied that signal 
transduction pathways are directly responsible for the re- 
moval of IKB from NF-KB. Another important property of 
NF-KB regulation is that activation is typically transient. 
Shortly after stimulation of cells with inducers of NF-KB, 
newly formed NF-KB-IKB complexes begin to reaccumu- 
late in the cytoplasm (Beg et al., 1993; Brown et al., 1993; 
Cordle et al., 1993; Henkel et al., 1993; Sun et al., 1993). 
Concurrently, NF-KB binding activity within the nucleus 
subsides. In the years since the initial characterization 
of the inducible nature of NF-KB, intense research has 
centered on elucidating the signaling events responsible 
for the dissociation of IKB from NF-KB in vivo. Moreover, 
investigators have worked to comprehend the mecha- 
nisms governing the transient nature of activation. A cru- 
cial step toward understanding these complex events was 
the characterization of proteins that comprise both the 
NF-KB and the IKB families. 
NF-KB and IKB Are Each Composed of a Family 
of Proteins 
Classic NF-KB is a heterodimer of a 50 kDa subunit (NF- 
KB~ or ~50) and a 65 kDa subunit (RelA or ~65) (Baeuerle 
and Baltimore, 1989; Kawakami et al., 1988). Cloning of 
the cDNAs encoding these proteins revealed two im- 
portant features (Ghosh et al., 1990; Kieran et al., 1990; 
Nolan et al., 1991; Ruben et al., 1991). First, both proteins 
are homologous to the product of the c-Rel proto- 
oncogene and second, the 50 kDa subunit is derived from 
the amino terminal portion of a precursor protein, ~105 
(see Figure 1). Unexpectedly, ~105 was also found to con- 
tain a cluster of so-called ankyrin or cell cycle repeats at 
its carboxyl terminus. The homology that exists among 
~50, ~65, and c-Rel is within an approximately 300 aa 
region, the Rel homology domain, which is common to all 
NF-KB family members (Figure 1). This essential region 
is multifunctional, controlling NF-KB dimerization, interac- 
tion with IKB, DNA binding, and it also contains the nuclear 
localization signal. The two other protein subunits within 
the NF-KB family are RelB and p52 (NF-KBP) (Schmid et 
al., 1991; Ryseck et al., 1992; Bours et al., 1992; Mercurio 
et al., 1992). Like ~50, p52 is initially expressed as an 
ankyrin repeat-containing precursor protein termed ~100. 
Proteins that constitute the NF-KB family form a variety 
of homo- and heterodimers, which have varying affinities 
for related NF-KB DNA binding sites. The structure of one 
of these NF-KB complexes bound to DNA, specifically the 
Rel homology domain of ~50 homodimers, has recently 
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Figure 1. Schematic Diagram of Members of 
the NF-KB and of the IKB Family of Proteins 
The Rel domain (shown in red) is approximately 
300 aa in length, is found in all NF-xB family 
members, and is required for dimerization, 
DNA binding, interaction with IxB, and con- 
tains the nuclear localization signal. Ankyrin 
repeats (shown in blue) are roughly 33 aa in 
length, are found in all IkB family members, 
and are necessary for the interaction of IKE 
with NF-KB. Processing sites for p105/p50 and 
plOO/p52 are indicated with arrows. All pro- 
teins are of mammalian origin except for dor- 
sal, Dif, and cactus, which are found in Dro- 
sophila. Refer to the text for details. 
been determined by X-ray crystallography techniques 
(Ghosh et al., 1995; Muller et al., 1995). The two comple- 
mentary studies impressively reveal a DNA binding do- 
main for NF-KB unrelated to those found in previously 
characterized proteins. During binding, ~50 homodimers 
envelop the DNA through a series of interactions dis- 
persed along the Rel homology domain, resulting in a 
three-dimensional structure that resembles a butterfly. 
Most of the various homo- and heterodimeric NF-KB 
complexes detected in vivo are regulated by IKB-mediated 
cytoplasmic retention. The cloning of a major form of IKB, 
IKBa, revealed that it contained a number of ankyrin re- 
peats similar to those found in the precursor ~105 (see 
Figure 1) (Haskill et al., 1991). Ankyrin repeats, each of 
which are roughly 33 aa in length, are found in a variety 
of unrelated proteins and have been implicated in protein- 
protein interactions (Thompson et al., 1991). Consistent 
with this role, the ankyrin repeats of IKB are required for 
interaction with NF-KB (Inoue et al., 1992; Hatada et al., 
1992,1993; Bours et al., 1993). A number of papers have 
provided conclusive data that lKBa inhibits NF-KB activity 
by sequestering it in the cytoplasm (Beg et al., 1992; Gan- 
chi et al., 1992; Zabel et al., 1993). Subsequent studies 
have demonstrated that ~105 and ~100 can similarly func- 
tion as IKBS (Rice et al., 1992; Mercurio et al., 1992; Nau- 
mann et al., 1993; Scheinman et al., 1993). The processing 
of ~105 and ~100 then yields active p50- and p52- 
containing NF-KB complexes that have the capacity to 
translocate into the nucleus. Therefore, the precursors to 
~50 and ~52 can be viewed as members of the IKB family, 
while the processed proteins belong to the NF-KB family. 
There are at least two other mammalian members of the 
IKB family, l~Bf3 and Bcl-3, both of which also contain 
ankyrin repeats. The cloning of l~Bf3 eluded researchers 
until very recently (Thompson et al., 1995). This study con- 
firmed that IKBP functions similarly to h&a, ~105, and 
pi 00 in its ability to regulate NF-KB by cytoplasmic reten- 
tion. However, as discussed later, it was also demon- 
strated that IKB~ exhibits unique characteristics that func- 
tionally distinguish it from lrcBa. In contrast with the other 
forms of IKB, Bcl-3 is predominantly nuclear and may actu- 
ally enhance NF-KB activity by serving as a transcriptional 
coactivator for ~50 or ~52 homodimers (Fujita et al., 1993; 
Bours et al., 1993). Although studies have implicated each 
form of IKB discussed above as a potential target in the 
control of NF-KB function, the majority of the research has 
focused on the roles of h&a, ~105, and, to a lesser extent, 
IKB~, in NF-KB regulation. For this reason, our discussion 
will primarily be limited to these molecules. 
A system strikingly similar to NF-KB and IKB exists in 
Drosophila. In this invertebrate, two Rel-related DNA bind- 
ing proteins, dorsal and Dif, are regulated by cytoplasmicl 
nuclear localization (Roth et al., 1989; Rushlow et al., 
1989; Steward, 1989; Ip et al., 1993). Cytoplasmic reten- 
tion of dorsal (and most likely Dif) is modulated via interac- 
tion with an ankyrin repeat-containing inhibitor known as 
cactus (Geisler et al., 1992; Kidd, 1992). Dorsal plays a 
critical role in dorsoventral patterning during early Dro- 
sophila embryogenesis. In addition, dorsal and Dif are im- 
plicated as important mediators of the immune response 
in Drosophila(lpet al., 1993; alsosee Ipand Levine, 1994). 
This evolutionary conservation in both structure and func- 
tion of NF-KB and IKB families attests to the critical impor- 
tance of this transcription factor in essential cellular pro- 
cesses, particularly those associated with immune system 
function. 
Postulated Mechanism of NF-KB Activation 
Most studies examining the regulation of NF-KB have fo- 
cused on hcBa. Consistent with the integral role phospho- 
ryl transfer plays in signal transduction, a widely held 
model explaining the mechanism of NF-KB activation 
stated that the inducible phosphorylation of hcBa was suffi- 
cient for its dissociation from NF-KB. This model was ini- 
tially based on several studies analyzing the role of phos- 
phorylation in vitro (Shirakawa and Mizel, 1989; Ghosh 
and Baltimore, 1990) and was supported by the observa- 
tion that h&a is phosphorylated in vivo following treatment 
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of cells with agents that activate NF-KB (Beg et al., 1993; 
Cordle et al., 1993; Mellits et al., 1993). lKBa also exhibits 
a basal level of phosphorylation that appears to be distinct 
from that induced by stimuli which activate NF-KB (Dido- 
nato et al., 1995; Brown et al., 1995). An additional obser- 
vation of the in vivo studies was the somewhat surprising 
result that lKBa is rapidly degraded following the phos- 
phorylation event (Beg et al., 1993; Brown et al., 1993; 
Cordleet al., 1993; Henkel et al., 1993; Mellitset al., 1993; 
Sun et al., 1993). The degradation of h&a was thought 
to occur after its dissociation from NF-KB, a proposal sup- 
ported by datademonstrating that within the cell, free lKBa 
is extremely labile, whereas that which is complexed to 
NF-KB is relatively stable (Scott et al., 1993; Sun et al., 
1993; Rice and Ernst, 1993). Thus, according to this preva- 
lent model (also see Beg and Baldwin, 1993) inducible 
phosphorylation causes lKBa dissociation and therefore 
NF-KB activation. After dissociation, uncomplexed h&a 
would be rapidly degraded. 
Phosphorylation of IKE Is Not Sufficient 
for NF-KB Activation 
Although avariety of data was consistent with this popular 
model of NF-KB activation, two more direct experimental 
approaches have recently yielded results that strongly ar- 
gue that the inducible phosphorylation of lKBa alone is 
not sufficient for NF-KB activation. First, a number of pa- 
pers have shown that the phosphorylated form of fKBa 
induced by TNF, LPS, and other agents remains associ- 
ated with NF-KB (Sun et al., 1994b; Traenckner et al., 
1994; Finco et al., 1994; Miyamoto et al., 1994b; Lin et 
al., 1995; Didonato et al., 1995; Alkalay et al., 1995). For 
these experiments, NF-KB and associated proteins were 
immunoprecipitated from extractsof stimulated cells using 
antibodies specific for NF-KB. The resulting immunopre- 
cipitate was then assayed for the presence of phosphory- 
lated lKBa. The criterion for inducibly phosphorylated 
lKBa utilized in these and most other studies is its reduced 
mobility when analyzed by Western blot. 
In the second approach, it was demonstrated that pre- 
treatment of cells with peptide aldehydes blocked the sub- 
sequent activation of NF-KB and resulted in the accumula- 
tion of inducibly phosphorylated lKBa (Palombella et al., 
1994; also see Traenckner et al., 1994; Miyamoto et al., 
1994b; Lin et al., 1995; Didonato et al., 1995; Alkalay et 
al., 1995). Thus, under these conditions, inducibly phos- 
phorylated lKBa is present within the cell but NF-KB is not 
activated. The simplest, most direct interpretation of this 
result is that the phosphorylated form off KBa is still associ- 
ated with NF-KB, thereby maintaining its ability to prevent 
NF-KB translocation into the nucleus. These results, to- 
gether with those obtained by coimmunoprecipitation, 
convincingly argue that the inducible phosphorylation of 
lKBa alone is not sufficient for dissociation. Furthermore, 
the results obtained using peptide aldehyde protease in- 
hibitors confirmed other observations, which suggested 
that an additional event required for NF-KB activation is 
IKB proteolysis. 
Proteolysis of IKB Is Required for NF-KB Activation 
Studies analyzing the role of proteolysis in NF-KB activa- 
tion can be divided into two groups, depending on the type 
of protease inhibitor used. One group of studies utilized 
serine protease inhibitors, while the second group em- 
ployed the previously mentioned peptide aldehydes, 
which are protease inhibitors that target various proteolytic 
activities, including calpains and the proteasome. The 
seminal study that indicated IKB degradation was essen- 
tial for NF-KB activation came from the use of serine prote- 
ase inhibitors. Pretreatment of cells with any of several 
serine protease inhibitors blocked the degradation of h&a 
and correspondingly prevented the nuclear translocation 
of NF-KB (Henkel et al., 1993). Since then, others using 
the same protease inhibitors have reported similar results 
(Mellits et al., 1993; Finco et al., 1994; Mackman, 1994; 
Miyamoto et al., 1994a; Machleidt et al., 1994). Other 
forms of IKB that are targeted in the activation of NF-KB, 
specifically ~105 and l~Bf3, were also effected by the ser- 
ine protease inhibitors (Mellits et al., 1993; Thompson et 
al., 1995). Together, these results suggested that the pro- 
teolysis of various forms of IKB was required for NF-KB 
activation, a conclusion subsequently confirmed through 
the use of peptide aldehyde protease inhibitors. Impor- 
tantly, the studies using peptide aldehydes also pointed 
to the proteasome as the proteolytic activity within the cell 
that degrades IKB. However, prior to the discussion of 
data concerning the proteasome and NF-KB activation, a 
brief summary of important observations made in further 
studies employing serine protease inhibitors is warranted. 
Serine Protease Inhibitors Prevent the Inducible 
Phosphorylation of h&a 
Additional studies employing serine protease inhibitors 
showed that they have significant pleiotropic effects on 
NF-KB. Some of the serine protease inhibitors can directly 
modify NF-KB and inhibit its DNA binding activity (Finco 
et al., 1994). In addition, and perhaps of more importance, 
all of the serine protease inhibitors examined block the 
inducible phosphorylation of lKBa and ~105 (Mellits et al., 
1993; Sun et al., 1994b; Finco et al., 1994; Miyamoto et 
al., 1994b; Didonato et al., 1995; Alkalay et al., 1995). 
These results raise a number of critical issues. First, the 
ability of some serine protease inhibitors to inhibit NF-KB 
DNA binding directly indicates that they in particular may 
not be ideal reagents for studies on this transcription fac- 
tor. Second, the observation that serineprotease inhibitors 
block inducible phosphorylation of lKBa suggests that 
these protease inhibitors may actually prevent NF-KB acti- 
vation through their inhibition of lKBa phosphorylation and 
not its degradation. This result also raises the intriguing 
question as to how all of these mechanistically distinct 
serine protease inhibitors prevent inducible phosphoryla- 
tion of lK-Ba. One possibility is that these protease inhibi- 
tors are targeting an additional upstream serine protease, 
which directly or indirectly regulates the kinase that phos- 
phorylates lKBa. Unlikeserine proteaseinhibitors, peptide 
aldehydes do not inhibit NF-KB DNA binding, nor do they 
prevent inducible phosphorylation of kBa. 
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The Proteasome Is the Proteolytic Activity 
Responsible for IKE Degradation 
Since one prominent target of peptide aldehydes is the 
proteasome, it was conceivable that this proteolytic com- 
plex was responsible for IKB degradation. The proteasome 
is a large multisubunit complex found in both the cyto- 
plasm and nucleus. The ATP-dependent 26s (1500 kDa) 
proteasome complex completely degrades certain ubiqui- 
tinated and nonubiquitinated substrates, including short- 
lived, long-lived, and abnormal proteins (for review, see 
Ciechanover, 1994). By varying the type and concentra- 
tion of peptide aldehyde added to cells, it is possible to 
distinguish whether the effects of these agents are due 
to their inhibition of the proteasome or instead other known 
protease targets, such as the calpains (Rock et al., 1994). 
Utilizing this information, and by analyzing the effects of 
other protease inhibitors, a number of studies postulated 
that the proteasome may be responsible for lkBa degrada- 
tion during NF-KB activation (Palombella et al., 1994; 
Traenckner et al., 1994; Alkalay et al., 1995; Didonato et 
al., 1995; Lin et al., 1995). A more recent paper provides 
substanial evidence that supports and significantly ex- 
Figure 2. A Model forthe Mechanism of NF-KB 
Activation 
Inducible phosphovlation of IrcBa and ~105 
targets these molecules for ubiquitination and 
subsequent proteolysis in situ by the protea- 
some. Liberated NF-xB then translocates into 
the nucleus, where it modulates gene expres- 
sion. Although not shown here, inducible deg- 
radationof kB6mayoccur byasimilar mecha- 
nism. Note that basal levels of phosphotylation 
on either NF-KB subunits or the various forms 
of IKB are not depicted. Refer to the text for 
details. 
tends this conjecture (Chen et al., 1995). This revealing 
study demonstrated that lKBa is ubiquitinated in vivo fol- 
lowing treatment of cells with inducers of NF-KB and that 
the ubiquitinated form isdegraded by the26S proteasome. 
Importantly, ubiquitinated l&a remains associated with 
NF-KB, strongly supporting the idea that h&a degradation 
occurs while still complexed to NF-KB (i.e., in situ). 
Further evidence demonstrating proteasome involve- 
ment in NF-KB activation comes from a detailed study of 
~105 processing (Palombella et al., 1994). This research 
revealed that ~105 is processed to a form similar to ~50 
in vitro by an ATP-dependent mechanism that requires 
both ubiquitination and the presence of proteasomes. In 
addition, mutant yeast strains that are defective in protea- 
some subunits are incapable of processing ~105 to ~50. 
Furthermore, the peptide aldehydeprotease inhibitorsthat 
are known to inhibit proteasome function also block pi05 
processing both in vitro and in vivo. One remarkable fea- 
ture of ~105 processing by the proteasome is that of con- 
trolled proteolysis, resulting in the degradation of only a 
portion of the ~105 protein. This suggests a novel mecha- 
nism by which the proteasome is able to modulate pre- 
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cisely the extent to which it may degrade a protein sub- 
strate. In summary, these studies together indicate that 
IKB proteolysis is necessary for NF-KB activation and sug- 
gest that the proteolytic activity within the cell that is re- 
sponsible for the degradation or processing of various 
forms of IKB is the proteasome. 
A Unifying Mechanism of NF-KB Activation: 
Phosphorylation of IKB Signals Ubiquitination 
and Subsequent Degradation by the Proteasome 
Since the inducible phosphorylation of lKBa does not re- 
sult in its dissociation from NF-KB, what, if any, is the 
function of this posttranslational modification? One possi- 
bility was that the phosphorylation of lrBa targets it for 
ubiquitination and that the ubiquitinated form is then de- 
graded by the proteasome in situ (see Figure 2). Recent 
papers provide compelling evidence that supports this 
model. Two serine residues in the amino terminus of lK-Ba 
have been identified as potential phospho-acceptor sites 
during NF-KB activation (Brown et al., 1995; Brockman et 
al., 1995; Traenckner et al., 1995). As one would expect, 
mutation of these serines to glycines or alanines prevented 
inducible phosphorylation, as indicated by the elimination 
of the characteristic shift in Ida mobility detected on 
Western blot. Significantly, mutation of these sites also 
prevented inducible degradation. The previously described 
study by Chen et al. (1995) then “closes the circle” by 
showing that mutation of the two serines also prevents 
the ubiquitination of lKBa. Thus, blocking inducible phos- 
photylation on lKBa eliminates ubiquitination and thereby 
prevents proteasome-driven degradation. The ability to 
control proteasome activity towards specific substrates by 
inducible phosphorylation may explain how a constitu- 
tively active proteolytic activity, the proteasome, can par- 
ticipate in inducible processes, such as the degradation 
of lKBa. However, it is conceivable that inducible alter- 
ations to the proteasome or the enzymes responsible for 
ubiquitination further enhance degradation of particular 
substrates, including lKBa. 
It has now been shown that ~105 is also inducibly phos- 
phorylated (Mellits et al., 1993; Naumann and Scheidereit, 
1994; Li et al., 1994a). It is likely that the phosphorylation 
of ~105 facilitates recognition of this molecule by the en- 
zymes responsible for ubiquitination, followed by its pro- 
teasome-driven processing to the ~50 form of NF-KB (see 
Figure 2). Contrary to this suggestion, the in vitro studies 
by Palombellaet al. (1994) imply that inducible phosphory- 
lation of ~105 may not be required for its processing. How- 
ever, their studies apparently focus on ~105 that is not 
associated with NF-KB family members. Under normal cel- 
lular conditions, ~105 is typically found complexed to NF- 
KB proteins. An attractive explanation of this disparity is 
that the requirements for ~105 processing (and lKBa deg- 
radation) differ depending on whether they are complexed 
to NF-KB family members. Phosphorylation of ~105 and 
lKBa may be required for processing or degradation of 
these proteins by the proteasome when complexed to NF- 
KB but not when free within the cell. This would also ex- 
plain the observed differential stability of free lKBa versus 
that complexed to NF-KB. The phosphorylation of hcBa 
and ~105 may cause a conformational change in these 
proteins, exposing sequences required for recognition by 
ubiquitin-conjugating enzymes, the proteasome, or both. 
PEST sequences, which are believed to target proteins 
for degradation, are found in the carboxyl terminus of both 
lrcBa and ~105 and may serve this function. In agreement 
with this notion, deletion of the Carboxyl terminus of lKBa, 
including the PEST region, does not alter inducible phos- 
phorylation but does prevent degradation (Brown et al., 
1995; Rodriguez et al., 1995). IKBP also contains a PEST- 
like region, which could act in asimilar manner(Thompson 
et al., 1995). 
An important point concerning the model in Figure 2 is 
that although the proteolysis of ~105, lKBa, and perhaps 
l~Bf3 may occur by similar if not identical mechanisms, 
some studies have indicated that the kinetics of these 
events differ (Mellits et al., 1993; Cordle et al., 1993; Don- 
ald et al., 1995; Thompson et al., 1995). It is possible that 
a rate-limiting step, for instance, the phosphorylation of 
lKBa, ~105, and l~Bj3, is regulated by distinct kinases with 
different rates of activation. This implies that the signal 
transduction pathway leading to NF-KB activation may bi- 
furcate upstream of IKB. However, it is also possible that 
alternative relative conformations for ~105, Ida, and 
IKB~ may affect the rate at which these molecules are 
recognized by the enzymes responsible for phosphoryla- 
tion, ubiquitination, and/or proteolysis. 
Reestablishment of Inactive NF-KB-IKB 
Complexes in the Cytoplasm 
As briefly discussed earlier, NF-KB activation is typically 
transient. After a period of stimulation, new inactive NF- 
KB-IKB complexes can be detected in the cytoplasm with 
an accompanying loss of active NF-KB in the nucleus. 
Analysis of lKBa protein levels following treatment of cells 
with different inducers showed that after its initial loss, 
lKBa begins to reaccumulate in the cytoplasm (Beg et al., 
1993; Brown et al., 1993; Sun et al., 1993; Henkel et al., 
1993). The reappearance of b&a protein was mirrored by 
an increase in its mRNA and was inhibited by pretreating 
cells with protein synthesis inhibitors (Beg et al., 1993; 
Brown et al., 1993; Sun et al., 1993; Henkel et al., 1993; 
Chiao et al., 1994). Therefore, it appears that a conse- 
quence of NF-KB activation is the enhanced production 
of lKBa protein. One exciting possibility was that this in- 
crease is the result of NF-KB-mediated expression of the 
hcBa gene. Data from a number of important studies have 
demonstrated the presence of this intriguing mechanism 
of negative autoregulation. First, lKBa gene expression 
is potently up-regulated by all inducers of NF-KB analyzed. 
Second, the transfection of NF-KB subunits into cells acti- 
vates transcription of the endogenous lKBa gene (Brown 
et al., 1993; Sun et al., 1993; Scott et al., 1993). Finally, 
the promoter immediately upstream of the lrcBa gene con- 
tains a number of near-perfect NF-KB binding sites (de 
Martin et al., 1993; Le Bail et al., 1993; Chiao et al., 1994; 
Ito et al., 1994). These sites bind NF-KB in vitro and are 
essential for reporter gene expression when driven by the 
ida promoter. The promoter regions of the genes encod- 
ing ~105 and ~100 also contain NF-KB binding sites and 
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Figure 3. Mechanisms that Contribute to the 
Transient Activation of Transcription Factor 
NF-KB 
(1) Treatment of cells with any of a variety of 
NF-KB inducers results in the proteolysis of IKE. 
(2) Liberated NF-KB is translocated into the nu- 
cleus. 
(3) In the nucleus, NF-I& activates a variety 
of genes, including those encoding IKB and 
NF-KB subunits. 
(4) Activation of IKB and NF-KB genes results 
in the appearance of IKB and NF-KB protein in 
the cytoplasm. 
(5) IrcB and NF-KB complexes associate to form 
new NF-ICE-IKB complexes, which are poised 
for the next round of activation. 
(6) Removal of transcriptionally engaged NF- 
KB complexes from the nucleus is dependent 
on protein synthesis and likely involves the dif- 
fusion of free lKBa into the nucleus. lKBa can 
actively remove NF-KB from the DNA, after 
which the complex either retro-translocates 
into the cytoplasm or is perhaps degraded. In 
addition, uncomplexed NF-rcB may be de- 
graded by a nuclear protease. Refer to the text 
for details. 
these genes are regulated in a manner similar to IKBa 
(Bours et al., 1990; Meyer et al., 1991; Mercurio et al., 
1992; Ten et al., 1992; Cogswell et al., 1993; Liptay et al., 
1994; Sun et al., 1994a). Moreover, the transcription of 
genes encoding NF-KB subunits, such as c-Rel and RelB, 
also appear to be activated by NF-KB (Bull et al., 1989; 
Hannink and Temin, 1990; Ryseck et al., 1992). Although 
~65 gene expression is not regulated by stimuli that acti- 
vate NF-KB and its promoter lacks NF-KB binding sites, 
the gene is constitutively expressed at a significant basal 
level (Ruben et al., 1991; Ueberla et al., 1993). From this 
data, it appears that the reestablishment of NF-KB-IKB 
complexes in the cytoplasm following activation of NF-KB 
is in part a result of de novo protein synthesis of various 
forms of IKB and NF-KB (see Figure3). The ability of NF-KB 
to stimulate expression of various forms of its inhibitor is 
an efficient means of maintaining a transient nature of 
activation. 
The other aspect of control in the transient activation 
of NF-KB is the loss of transcriptionally active NF-KB from 
the nucleus. NF-KB typically resides in the nucleus for a 
limited period of time. For example, the removal from cells 
of stimuli such as TNF results in a steady reduction of 
nuclear NF-KB (Hohmann et al., 1991; Brown et al., 1993; 
Arenzana-Seisdedos et al., 1995). Experimental data indi- 
cates that two distinct mechanisms are responsible for this 
decline. The first is an inducible active process involving a 
newly synthesized protein, which is most likely lrcBa, and 
the second, a more constitutive system where nuclear NF- 
KB is degraded, possibly by normal protein turnover. The 
suggestion that lK-Ba may down-regulate NF-KB activity 
in the nucleus was initially based on the observation that 
lKBa can directly disengage NF-KB from DNA (Zabel and 
Baeuerle, 1990). It was proposed that newly synthesized 
licBa enters the nucleus, binds to, and removes NF-KB 
from the DNA. Then, the NF-KB-IKBa complexes either 
retro-translocate into the cytoplasm or are instead de- 
graded within the nucleus (see Figure 3). A variety of stud- 
ies have presented evidence consistent with this model. 
First, loss of NF-KB from the nucleus is severely curtailed 
when protein synthesis is inhibited, presumably because 
lKBa protein is not synthesized (Chiao et al., 1994; Sun 
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et al., 1993; Arenzana-Seisdedos et al., 1995). Second, 
overexpression of lKBa reSUlts in its diffusion into the nu- 
cleus (Zabel et al., 1993; Cressman and Taub, 1993). This 
demonstrates that hcBa can enter the nucleus when ex- 
pressed at high levels, a situation which would likely exist 
following activation of lKBa gene expression by NF-KB. 
Indeed, under more physiological conditions, endogenous 
h&a enters the nucleus following its synthesis in response 
to NF-KB inducers (Arenzana-Seisdedos et al., 1995). Im- 
portantly, the appearance of lKBa in the nucleus and its 
subsequent departure correlated temporally with the loss 
of nuclear NF-KB DNA binding. In addition, and consistent 
with the proposed model, a direct interaction between 
lrcBa and NF-KB could be detected within the nucleus. 
In the absence of NF-KB removal by kBa, the transcrip- 
tion factor may be degraded. This is suggested by the 
observation that nuclear NF-KB activity eventually dimin- 
ishes even in the presence of protein synthesis inhibitors 
(Chiao et al., 1994; Cressman and Taub, 1994) and also 
by a study proposing that proteolysis can contribute to the 
turnover of nuclear NF-KB (Cressman and Taub, 1994). 
The picture that emerges is one where the removal of 
NF-KB from the nucleus is typically an active process that 
requires protein synthesis and likely involves lKBa. Con- 
current with or in the absence of this mechanism, nuclear 
NF-KB may be degraded by a nuclear protease. 
Transient Versus Constitutive 
or Persistent Activation 
Although NF-KB activation is typically transient, situations 
do exist where members of this transcription factor family 
are activated for prolonged periods. The two examples 
summarized below illustrate how cells, under necessary 
physiological conditions, are able to override the estab- 
lished mechanisms that favor only transient activation. 
The first example focuses on constitutively active forms of 
NF-KB found in mature B lymphocytes(Sen and Baltimore, 
1986). In contrast with most cell types, mature B cells 
degrade lKBa at a rate that exceeds its synthesis, resulting 
in the constitutive nuclear translocation of a small but sig- 
nificant amount of NF-KB (Rice and Ernst, 1993; Miyamoto 
et al., 1994a; Liou et al., 1994). Thus, one means bywhich 
cells can overcome transient activation of NF-KB is to stim- 
ulate pathways responsible for lKBa proteolysis, possibly 
through the up-regulation of signal-transducing mole- 
cules. The rate of Ida synthesis versus degradation may 
therefore influence whether NF-KB is activated transiently 
or constitutively. The second example pertains to certain 
inducers such as LPS and IL-l, which cause a persistent 
activation of NF-KB (Thompson et al., 1995). As shown in 
previous studies, treatment of cells with either TNF, IL-l, 
PMA, or LPS resulted in the rapid degradation of lKBa 
concomitant with NF-KB translocation into the nucleus. 
The intriguing observation of this study was that persistent 
inducers (LPS, IL-l) but not transient ones (PMA, TNF) 
also targeted IKB~. Treatment of cells with LPS or IL-1 
resulted in the degradation of IKB~, albeit at slower kinet- 
ics than for hcBa. Importantly, l~Bf3 protein did not reaccu- 
mulate within the cytoplasm following activation, a result 
consistent with the inability of NF-KB inducers to increase 
IKB~ RNA levels. Apparently, only after removal of the 
inducer would IKBP protein levels be reestablished. The 
authors propose that the rapid degradation of lKBa in re- 
sponse to various inducers releases NF-KB complexes 
involved in the initial transient activation while the slower 
sustained down-regulation of l~Bf3 yields NF-KB, which 
persistently resides in the nucleus. If this model is correct, 
a mechanism must exist that prevents newly synthesized 
kBa from binding to and sequestering NF-KB released 
from l~Bf3. Nonetheless, these results suggest that an- 
other means by which cells overcome the transient na- 
ture of NF-KB activation is by targeting forms of IKB other 
than hcBa. 
Concluding Remarks 
The existence of multiple forms of IKB in mammalian cells 
suggests alternative ways of regulating NF-KB activity, 
thereby allowing members of this transcription factor fam- 
ily to participate in a variety of cellular events. The pro- 
posed roles of lKBa and l~Bf3 in transient and persistent 
activation, respectively, demonstrates the relevance of 
this postulation. It will be important to define further how 
each form of IKB contributes to the regulation of NF-KB 
during different cellular responses. 
Clearly, for NF-KB regulation to be sufficiently under- 
stood, the detailed elucidation of signal transduction path- 
ways that target NF-KB-IKB complexes is crucial. At pres- 
ent, only general considerations can be made. The ability 
of such a large number of distinct biological agents to 
activate NF-KB suggests that multiple pathways may re- 
sult in IKB removal and therefore NF-KB activation. In ac- 
cordance with thisview, an increasing number of divergent 
signal-transducing molecules are being implicated in NF- 
KB activation. Conversely, other research has indicated 
that most if not all inducers of NF-KB utilize a common 
redox-sensitive step in the activation of NF-KB (Siebenlist 
et al., 1994; Baeuerle and Henkel, 1994). Perhaps initially 
distinct pathways converge on a common pathway, which 
then targets individual NF-KB-IKB complexes. Another 
topic concerning signal transduction and the different IKB 
molecules is whether the various IKBS are targeted by 
the same pathway? As discussed earlier, it appears that 
similar mechanisms, i.e., phosphorylation-induced pro- 
teolysis, regulate the activity of manyformsof IKB. In addi- 
tion, inducible degradation of Ida, IKBP, and ~105 is sen- 
sitive to pretreatment of cells with anti-oxidants or the 
serine protease inhibitor and alkylating agent TPCK. 
These observations suggest that highly similar or identical 
pathways target each of the different IKB molecules. How- 
ever, the kinetics by which various types of IKB are phos- 
phorylated and degraded differ. Furthermore, some in- 
ducers only target one form of IKB, while others target 
multiple forms, implying that alternative signaling path- 
ways exist. Further research should clarify this issue. 
Much of the research on NF-KB regulation has concen- 
trated on inducible modifications to IKB. However, recent 
studies have shown that NF-KB is also phosphorylated in 
an inducible manner (Neumann et al., 1992; Druker et al., 
1994; Naumann and Scheidereit, 1994; Li et al., 1994a; 
Diehl et al., 1995). Some studies have indicated that phos- 
Immunity 
270 
phorylation of NF-KB family members is important in regu- 
lating its DNA binding capacity (Hayashi et al., 1993; Nau- 
mann and Scheidereit, 1994; Li et al., 1994b). It is 
anticipated that modifications to NF-KB, including phos- 
phorylation, are also important for other functions, possi- 
bly contributing to the removal of IKB, translocation of 
NF-KB into the nucleus, and enhancement of NF-KB trans- 
activation capabilities. 
In summary, this review has discussed the mechanisms 
by which cells regulate members of the NF-KB transcrip- 
tion factor family. The general theme that emerges from 
these studies is that the exquisite control of NF-KB function 
is cummulative in nature, requiring the coordinated phos- 
phorylation and proteolysis of both NF-KB and IKB pro- 
teins. 
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